 |
|
|
|
Radiation Oncology Research
 There is a long standing tradition of both basic and clinical research within our department.While our faculty are free to pursue "good ideas" wherever they might lead, our broad aim is to improve treatment results for the cancer patient.
We are a leading institution in medical informatics research relating to radiation treatment planning and delivery and fast neutron radiotherapy research. Our Cancer Biology Group is engaged in understanding the genomic changes that lead to a malignant transformation and the relationship between changes of this type and the natural aging process.
Our Radiochemistry Division has developed special antibodies that target certain types of tumors and is exploring the use of an a-particle emitter, astatine-211, to kill tumor cells on which these antibodies localize. Our Medical Physics Group is developing improved techniques for delivering radiation beams to tumors with sparing of normal tissues which both improves tumor control and reduces treatment side effects. Our clinical faculty develops and participates in two types of clinical trials: phase I/II pilot studies to provide early data on the newest forms of therapy and phase III randomized studies which compare more developed therapies with the best available standard treatments. The later are often done in the context of multi-institutional cooperative groups. We have many active collaborations with researchers in other departments both at the University of Washington and at other institutions.
|
|
|
|
|
Copyright © 2002 University of Washington
|
